AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke.
Standard
AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. / Schäbitz, Wolf R; Laage, Rico; Vogt, Gerhard; Koch, Winfried; Kollmar, Rainer; Schwab, Stefan; Schneider, Dietmar; Hamann, Gerhard F; Rosenkranz, Michael; Veltkamp, Roland; Fiebach, Jochen B; Hacke, Werner; Grotta, James C; Fisher, Marc; Schneider, Armin.
In: STROKE, Vol. 41, No. 11, 11, 2010, p. 2545-2551.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke.
AU - Schäbitz, Wolf R
AU - Laage, Rico
AU - Vogt, Gerhard
AU - Koch, Winfried
AU - Kollmar, Rainer
AU - Schwab, Stefan
AU - Schneider, Dietmar
AU - Hamann, Gerhard F
AU - Rosenkranz, Michael
AU - Veltkamp, Roland
AU - Fiebach, Jochen B
AU - Hacke, Werner
AU - Grotta, James C
AU - Fisher, Marc
AU - Schneider, Armin
PY - 2010
Y1 - 2010
N2 - Granulocyte colony-stimulating factor (G-CSF) is a promising stroke drug candidate. The present phase IIa study assessed safety and tolerability over a broad dose range of G-CSF doses in acute ischemic stroke patients and explored outcome data.
AB - Granulocyte colony-stimulating factor (G-CSF) is a promising stroke drug candidate. The present phase IIa study assessed safety and tolerability over a broad dose range of G-CSF doses in acute ischemic stroke patients and explored outcome data.
M3 - SCORING: Zeitschriftenaufsatz
VL - 41
SP - 2545
EP - 2551
JO - STROKE
JF - STROKE
SN - 0039-2499
IS - 11
M1 - 11
ER -